{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:27Z","timestamp":1786505247380,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["23A0305"],"award-info":[{"award-number":["23A0305"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003824","name":"Hunan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ90032"],"award-info":[{"award-number":["2025JJ90032"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156528","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:56:19Z","timestamp":1778543779000},"page":"156528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pentadecylic acid from Bielong Ruangan Decoction (BLRGD) inhibits hepatocellular carcinoma (HCC) cell aggressiveness through the JAK2\/STAT3 pathway"],"prefix":"10.1016","volume":"286","author":[{"given":"Meixuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.prp.2026.156528_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00261-017-1209-1","article-title":"Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis","volume":"43","author":"Tang","year":"2018","journal-title":"Abdom. Radio."},{"key":"10.1016\/j.prp.2026.156528_bib3","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.prp.2026.156528_bib4","article-title":"Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1: miR-3130-5p Enhances HCC Growth via Inhibiting FDX1","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharm."},{"issue":"2","key":"10.1016\/j.prp.2026.156528_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3350\/cmh.2022.0402","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective","volume":"29","author":"Xie","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2026.156528_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.prp.2026.156528_bib7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.prp.2026.156528_bib9","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1634\/theoncologist.2019-0944","article-title":"Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.prp.2026.156528_bib10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.prp.2026.156528_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jep.2013.07.030","article-title":"Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma","volume":"149","author":"Hu","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.prp.2026.156528_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","article-title":"Molecular pathogenesis of human hepatocellular carcinoma","volume":"31","author":"Thorgeirsson","year":"2002","journal-title":"Nat. Genet"},{"issue":"4","key":"10.1016\/j.prp.2026.156528_bib13","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ptr.7757","article-title":"Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations","volume":"37","author":"Shelash Al-Hawary","year":"2023","journal-title":"Phytother. Res"},{"issue":"10","key":"10.1016\/j.prp.2026.156528_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4251\/wjgo.v12.i10.1091","article-title":"Synergistic anti-liver cancer effects of curcumin and total ginsenosides","volume":"12","author":"Deng","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.prp.2026.156528_bib15","series-title":"Studies in Natural Products Chemistry","first-page":"507","article-title":"Resveratrol oligomers: Structure, chemistry, and biological activity","author":"Cichewicz","year":"2002"},{"issue":"5","key":"10.1016\/j.prp.2026.156528_bib16","first-page":"582","article-title":"Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression","volume":"50","author":"Song","year":"2021","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12906-017-1956-0","article-title":"Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells","volume":"17","author":"Jiang","year":"2017","journal-title":"BMC Complement Alter. Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib18","first-page":"22","article-title":"Pathological study on the effects of Bielong Ruangan Tablets on liver fibrosis in experimental rats","volume":"20","author":"Lei","year":"2000","journal-title":"J. Hunan Coll. Tradit. Chin. Med."},{"issue":"6","key":"10.1016\/j.prp.2026.156528_bib19","first-page":"48","article-title":"A theoretical study on the intervention of liver cirrhosis and precancerous lesions of liver cancer with the method of nourishing the spleen and nourishing the liver","volume":"36","author":"Wang","year":"2018","journal-title":"J. Sichuan Tradit. Chin. Med."},{"issue":"9","key":"10.1016\/j.prp.2026.156528_bib20","first-page":"181","article-title":"Clinical study of Bielong Ruangan capsule on liver fibrosis","volume":"30","author":"Wang","year":"2010","journal-title":"J. Hunan Univ. Chin. Med."},{"issue":"11","key":"10.1016\/j.prp.2026.156528_bib21","first-page":"2152","article-title":"Clinical effect of Bielong Ruangan decoction combined with transcatheter arterial chemoembolization in treatment of hepatitis B virus-related primary liver cancer","volume":"33","author":"Wu","year":"2017","journal-title":"J. Clin. Hepatol."},{"issue":"6","key":"10.1016\/j.prp.2026.156528_bib22","first-page":"558","article-title":"Effect of Bielong Ruangan Tablet Combined with Entecavir on the Incidence of Liver Cancer in Patients with Hepatitis B Cirrhosis","volume":"42","author":"Yang","year":"2023","journal-title":"Shandong J. Tradit. Chin. Med."},{"key":"10.1016\/j.prp.2026.156528_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr. Genom."},{"issue":"9","key":"10.1016\/j.prp.2026.156528_bib25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3748\/wjg.v17.i9.1152","article-title":"Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2","volume":"17","author":"Zhao","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156528_bib26","doi-asserted-by":"crossref","first-page":"31694","DOI":"10.1038\/srep31694","article-title":"A simple non-perturbing cell migration assay insensitive to proliferation effects","volume":"6","author":"Glenn","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156528_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad027","article-title":"Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM","volume":"24","author":"Tian","year":"2023","journal-title":"Brief. Bioinform"},{"issue":"13","key":"10.1016\/j.prp.2026.156528_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310858","article-title":"Cisplatin in Liver Cancer Therapy","volume":"24","author":"Hamaya","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2026.156528_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061663","article-title":"Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7\/SC Human Breast Cancer Stem-Like Cells through JAK2\/STAT3 Signaling","volume":"12","author":"To","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/leu.2017.162","article-title":"PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells","volume":"32","author":"Sun","year":"2018","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.prp.2026.156528_bib31","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.44705","article-title":"Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156528_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106739","article-title":"\u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer","volume":"191","author":"Xu","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.prp.2026.156528_bib33","doi-asserted-by":"crossref","first-page":"21010","DOI":"10.1038\/srep21010","article-title":"\u03b2-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.prp.2026.156528_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911340","article-title":"Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7\/SC Breast Cancer Cells","volume":"23","author":"To","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.prp.2026.156528_bib35","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2217\/fon-2021-1623","article-title":"Locoregional treatments plus immunotherapy in hepatocellular carcinoma: where do we stand?","volume":"18","author":"Rizzo","year":"2022","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156528_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14712598.2026.2642273","article-title":"Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?","volume":"26","author":"Di Marco","year":"2026","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib37","doi-asserted-by":"crossref","first-page":"28309","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156528_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-026-10327-0","article-title":"Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis","volume":"45","author":"Vitale","year":"2026","journal-title":"Cancer Metastas. Rev."},{"issue":"10","key":"10.1016\/j.prp.2026.156528_bib39","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3748\/wjg.v10.i10.1487","article-title":"Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells","volume":"10","author":"Guo","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156528_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biopha.2017.08.011","article-title":"Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-beta1\/Smad and NFkappaB signaling","volume":"95","author":"Hu","year":"2017","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2013.03.067","article-title":"Effect of bioactive peptide of Carapax Trionycis on TGF-beta1-induced intracellular events in hepatic stellate cells","volume":"148","author":"Tang","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156528_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5582\/ddt.2013.v7.6.248","article-title":"Synthesis of peptides of Carapax Trionycis and their inhibitory effects on TGF-beta1-induced hepatic stellate cells","volume":"7","author":"Hu","year":"2013","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.prp.2026.156528_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.892945","article-title":"Bioactive Earthworm Peptides Produced by Novel Protease-Producing Bacillus velezensis PM 35 and Its Bioactivities on Liver Cancer Cell Death via Apoptosis, Antioxidant Activity, Protection Against Oxidative Stress, and Immune Cell Activation","volume":"13","author":"Wasunan","year":"2022","journal-title":"Front Microbiol."},{"issue":"2","key":"10.1016\/j.prp.2026.156528_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1631\/jzus.B0720194","article-title":"Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties","volume":"9","author":"Balamurugan","year":"2008","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.prp.2026.156528_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopha.2016.05.001","article-title":"The protective effect of the earthworm active ingredients on hepatocellular injury induced by endoplasmic reticulum stress","volume":"82","author":"Wang","year":"2016","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.prp.2026.156528_bib46","article-title":"Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B","author":"Kong","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/01635581.2023.2276525","article-title":"Radix Bupleuri-Radix Paeoniae Alba Inhibits the Development of Hepatocellular Carcinoma through Activation of the PTEN\/PD-L1 Axis within the Immune Microenvironment","volume":"76","author":"Zhang","year":"2024","journal-title":"Nutr. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2026.156528_bib48","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.3390\/ijms131114634","article-title":"Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs)","volume":"13","author":"Wang","year":"2012","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156528_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","article-title":"PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs","volume":"99","author":"He","year":"1999","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.prp.2026.156528_bib50","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1073\/pnas.97.24.13275","article-title":"Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer","volume":"97","author":"Gupta","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"31","key":"10.1016\/j.prp.2026.156528_bib51","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1073\/pnas.0705505104","article-title":"Transcriptional network governing the angiogenic switch in human pancreatic cancer","volume":"104","author":"Abdollahi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.prp.2026.156528_bib52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1165\/rcmb.2007-0426OC","article-title":"Peroxisome proliferator-activated receptor beta\/delta expression and activation in lung cancer","volume":"39","author":"Pedchenko","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91419","article-title":"Metastasis regulation by PPARD expression in cancer cells","volume":"2","author":"Zuo","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.prp.2026.156528_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121623","article-title":"Vascular PPARbeta\/delta Promotes Tumor Angiogenesis and Progression","volume":"8","author":"Wagner","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-022-03288-9","article-title":"Ligand-activated PPARdelta expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway","volume":"20","author":"Han","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib56","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","article-title":"N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib57","doi-asserted-by":"crossref","first-page":"19775","DOI":"10.1038\/s41598-022-23837-y","article-title":"DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression","volume":"12","author":"Dong","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13046-019-1456-9","article-title":"SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARdelta signalling-mediated alternative activation of macrophages","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.prp.2026.156528_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/hep.13.7","article-title":"STAT3 in hepatocellular carcinoma: new perspectives","volume":"1","author":"Svinka","year":"2014","journal-title":"Hepat. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156528_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.prp.2026.156528_bib62","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:41:55Z","timestamp":1786502515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0344033826001810"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156528","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentadecylic acid from Bielong Ruangan Decoction (BLRGD) inhibits hepatocellular carcinoma (HCC) cell aggressiveness through the JAK2\/STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156528"}}